Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1987-10-05
1989-09-12
Kight, John
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 9, 514 21, 514 42, 514 44, 514 46, 514 50, 514 75, 514 78, 514357, A61K 3702, A61K 3900, C07C10352
Patent
active
048660361
ABSTRACT:
Disclosed are specific dipeptidyl 5-0, 6-0-Acyl-2-amino-2-deoxy-D-glucofuranoses, which, either alone, or in combination with an anti-AIDS drug, e.g. azidothymidine, provide protection in human individuals whose resistance to infection has been specifically suppressed by an AIDS-related (HIV) virus, as well as help to suppress the AIDS-related infection itself.
REFERENCES:
patent: 4310514 (1982-01-01), Durette
Dagani; "Efforts Intensify to Develop Drugs, Vaccine that Combat Aids, " C & E News, Dec. 8, 1986, pp. 7-14.
Harbour John W.
Kight John
Merck & Co. , Inc.
North Robert J.
Nutter Nathan M.
LandOfFree
Dipeptidyl 5-0,6-0-acyl-2-amino-2-deoxy-D-glucofuranose composit does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dipeptidyl 5-0,6-0-acyl-2-amino-2-deoxy-D-glucofuranose composit, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dipeptidyl 5-0,6-0-acyl-2-amino-2-deoxy-D-glucofuranose composit will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-916282